Trial Profile
A Study to Evaluate the Exposure of Apixaban Using Different Laboratory Methods in Patients With Atrial Fibrillation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Apr 2016
Price :
$35
*
At a glance
- Drugs Apixaban (Primary)
- Indications Embolism and thrombosis; Stroke
- Focus Pharmacokinetics
- 25 Apr 2016 New trial record